ANALISIS BIAYA PENYAKIT DIABETES MELLITUS DI RSUP Dr. SARDJITO YOGYAKARTA

ELNY FITRI, Dr. Tri Murti Andayani, Sp.FRS., Apt.; dr. Endang Suparniati, M.Kes.

2015 | Tesis | S2 Ilmu Farmasi

Tingginya prevalensi dan timbulnya komplikasi menjadikan diabetes mellitus sebagai penyakit tidak menular kronis yang menimbulkan beban ekonomi yang signifikan bagi sistem pembiayaan kesehatan. Penelitian bertujuan untuk mengetahui total biaya penyakit, pengaruh faktor usia, komplikasi, lama rawat inap, dan kelas rawat inap terhadap biaya riil, dan perbedaan antara total biaya riil dengan total tarif paket INA-CBG’s pasien diabetes melitus periode Januari-Juni 2014 di RSUP Dr. Sardjito Yogyakarta. Penelitian ini merupakan penelitian analitik noneksperimental yang dilakukan secara retrospektif. Perspektif penelitian adalah rumah sakit dengan memperhitungkan biaya medik langsung menggunakan pendekatan bottom up. Sampel penelitian berjumlah 1.396 pasien dengan 1.935 episode perawatan. Variabel bebas meliputi usia, komplikasi, lama dan kelas rawat inap sedangkan variabel tergantung biaya riil pasien. Analisis data dilakukan menggunakan analisis statistik regresi berganda (multiple regression). Berdasarkan hasil penelitian didapatkan total biaya penyakit diabetes mellitus sebesar Rp 15.290.740.745. Hasil analisis regresi linier berganda menunjukkan bahwa faktor komplikasi dan lama rawat inap menjadi faktor yang paling berpengaruh terhadap biaya riil pasien diabetes mellitus rawat jalan dan rawat inap. Ada perbedaan atau selisih biaya antara total biaya riil dengan total tarif paket INA-CBG’s pada pasien DM tipe 1 rawat jalan, pasien DM tipe 1 rawat inap, DM tipe 2 rawat inap masing-masing sebesar Rp 46.511.644, Rp 100.647.901, Rp 186.542.144 dengan total biaya riil lebih kecil dibandingkan total tarif paket INA-CBG’s. Pada pasien DM tipe 2 rawat jalan didapatkan perbedaan atau selisih biaya sebesar Rp -196.698.235 dimana total biaya riil lebih besar dibandingkan total tarif paket INA-CBG’s. Kata Kunci: Analisis biaya, diabetes mellitus, INA-CBG’s

The high prevalence and complications of diabetes mellitus, as a chronic non-communicable disease, result a significant economic burden for the health care cost. This study aimed to calculate the total of illness cost; the effect of age, complication, the period and treatment class of inpatient on the real cost; and the difference between the total of real cost compared to the standard treatment cost of INA-CBG’s for diabetic patients in the period of January through June of 2014 in Dr. Sardjito hospital, Yogyakarta. This research was analytic non-experimental with retrospective approach. Research was conducted based on the hospital perspective by calculating the direct medical costs using a bottom-up approach. These samples included 1,396 patients with 1,935 episodes of care. The independent variables included age, complications, length of hospitalization and treatment class, while the dependent variable was the real cost. The data was analyzed using the multiple regression statistic analysis. The results showed that, the total cost of illness of diabetes mellitus was IDR 15,248,582,600. The multiple linear regression analysis showed that the complication and length of stay were the most influencing factors on the real costs of diabetic outpatients and inpatients. There was a difference between the real total cost and the standard treatment cost of INA-CBG's for patients with type 1 of diabetic outpatients, inpatients, and inpatient with type 2 diabetic around IDR 46,511,644, IDR 100,647,901 and IDR 186.542.144 in which the real total cost was lower then the INA-CBG's standard. Moreover, there was a difference in outpatients with type 2 DM around IDR -196,698,235, higher than the INA-CBG 's standard. Key words: Cost analysis, diabetes mellitus, INA-CBG 's.

Kata Kunci : Analisis biaya, diabetes mellitus, INA-CBG’s; Cost analysis